Wednesday - April 15, 2026

Category Archives: Pharmaceuticals & Biotech

Shop Genomics Streamlines Scientific Procurement by Bringing Consumer E-Commerce Standards to B2B Laboratory Supply

Scientific researchers should focus on discoveries, not navigate Byzantine procurement processes. By bringing the intuitive design and customer service standards of consumer e-commerce to laboratory supply, Shop Genomics eliminates friction that has plagued scientific purchasing for decades, ultimately accelerating the … Continue reading →

Degenerative Disc Disease Clinical Trial Analysis 2026: Recent FDA Clearances, Ongoing Clinical Studies, and Emerging Treatment Landscape by DelveInsight | Mesoblast, DiscGenics, Biosplice Therapeutic

Degenerative Disc Disease Pipeline According to DelveInsight’s evaluation, the global Degenerative Disc Disease (DDD) pipeline comprises more than 15 prominent companies actively advancing over 15 therapeutic candidates. The analysis encompasses clinical trials, therapeutic approaches, mechanisms of action, routes of administration, … Continue reading →

Juvenile Idiopathic Arthritis Market Set for Robust Expansion Through 2036 Driven by Innovative Biologics and Precision Therapies | DelveInsight

Juvenile Idiopathic Arthritis Market The Juvenile Idiopathic Arthritis market is entering a transformative phase, driven by rapid advancements in targeted therapeutics, increasing disease awareness, and improved diagnostic capabilities. Leading pharmaceutical companies such as Bristol-Myers Squibb, UCB Biopharma, Novartis, AbbVie, Sanofi, … Continue reading →

Pridopidine Market Forecast to 2034: Strong Clinical Momentum and ALS Expansion to Drive Pridopidine Sales Growth | DelveInsight

Pridopidine Sales Market Forecast The global Pridopidine market is gaining significant traction as Prilenia Therapeutics advances its investigational therapy across Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS). Backed by robust clinical evidence, strategic collaborations, and regulatory advantages, Pridopidine sales … Continue reading →

Pulmonary Arterial Hypertension pipeline is witnessing global growth, with over 55 therapies currently under development, according to DelveInsight’s market intelligence report.

Pulmonary Arterial Hypertension pipeline Pulmonary Arterial Hypertension companies, including Aerovate Therapeutics, Novartis, Keros Therapeutics, Vigonvita Life Sciences, Insmed Incorporated, Chugai Pharmaceutical, Merck Sharp & Dohme, Janssen Pharmaceutical, Actelion, Gossamer Bio, Lung Biotechnology PBC, United Therapeutics, Gilead Sciences, Acceleron Pharma, Eiger … Continue reading →

Balloon Valvuloplasty Device Market is projected to expand at a CAGR of 5.13% through 2032, fueled by the increasing prevalence of cardiovascular diseases states DelveInsight

Balloon Valvuloplasty Device Market Balloon valvuloplasty device manufacturers consist of BD, PFM Medical AG, NuMED, Balton, TORAY INDUSTRIES, INC., Translumina, InterValve Medical, Inc., OSYPKA AG, SURETECH MEDICAL INC., simeks, among others. The Global Balloon Valvuloplasty Device Market is expected to … Continue reading →

Best Functional Medicine Doctor in New Jersey | CX Research Institute Report

Independent research report ranks Springfield-based clinic highest for comprehensive hormone optimization, autoimmune care, root-cause diagnostics, and exceptional patient outcomes across New Jersey Springfield, NJ – CX Research Institute announced today the publication of its comprehensive research report evaluating the best … Continue reading →

Hepatocellular Carcinoma Clinical Trial Pipeline Expands as 90+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Hepatocellular Carcinoma Pipeline Insight 2026 report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in the Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Diabetic Macular Edema Clinical Trial Pipeline Shows Potential with Active Contributions from 45+ Key Companies | DelveInsight

DelveInsight’s “Diabetic Macular Edema Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Diffuse Large B-Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insights 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline landscape. It covers the Diffuse Large B-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical … Continue reading →